Paris, France, March 30 2021 - CET– Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost ...

Paris, France, April 21, 2021 – 18.00 CET– Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who have ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Electronic retinal implants like the PRIMA system can partially restore central vision in ...

NAPCO Security Technologies, Inc. announced the addition of new retrofit and takeover options for its award-winning Prima 7” Super Self-Contained Panel & Smart System. These latest enhancements ...

Please provide your email address to receive an email when new articles are posted on . The Prima System received breakthrough device designation for use in patients with dry age-related macular ...

PRIMA, miniaturized wireless photovoltaic sub-retinal implant, elicited visual perception in the first human subject with Atrophic Dry-AMD Pixium Vision (FR0011950641 - PIX), a company developing ...

Amityville, NY, NAPCO Security Technologies, Inc. is pleased to announce the addition of new retrofit and takeover options for its award-winning Prima 7” Super Self-Contained Panel & Smart System.

PARIS--(BUSINESS WIRE)--Regulatory News: Pixium Vision (Paris:PIX) (FR0011950641 - PIX), a company developing innovative bionic vision systems to enable patients who have lost their sight to lead more ...

Paris, France, April 7, 2021 – 7.00 a.m. CEST – Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who ...

We continue to value Pixium using an rNPV approach, employing a 12.5% cost of capital. Our valuation is based solely on the Prima opportunity in Dry-AMD. We continue to apply a probability of success ...

Pixium Vision announces positive long-term follow-up scientific data on PRIMA implant from Prima System French feasibility study PRIMA implant is well tolerated and safe in patients 36 months after ...